相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura
Berangere S. Joly et al.
EXPERT REVIEW OF HEMATOLOGY (2019)
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
Anand Padmanabhan et al.
JOURNAL OF CLINICAL APHERESIS (2019)
Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura
Nicolas Beranger et al.
THROMBOSIS RESEARCH (2019)
Comparison of ADAMTS13 and Von Willebrand factor levels and activities, and plasminogen levels, in plasma products currently available for the treatment of thrombotic thrombocytopenic purpura in South Africa
A. C. van Marle et al.
TRANSFUSION AND APHERESIS SCIENCE (2019)
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy
Eric Mariotte et al.
LANCET HAEMATOLOGY (2016)
Primary and Secondary Thrombotic Microangiopathy Referred to a Single Plasma Exchange Center for Suspected Thrombotic Thrombocytopenic Purpura: 2000-2011
Randah Dahlan et al.
AMERICAN JOURNAL OF NEPHROLOGY (2015)
Haemostatic profile of reconstituted blood in a proposed 1:1:1 ratio of packed red blood cells, platelet concentrate and four different plasma preparations
M. Ponschab et al.
ANAESTHESIA (2015)
Type of plasma preparation used for plasma exchange and clinical outcome of adult patients with acquired idiopathic thrombotic thrombocytopenic purpura: a French retrospective multicenter cohort study
Marie Toussaint-Hacquard et al.
TRANSFUSION (2015)
Safety and Efficacy of Cryoprecipitate-Poor Plasma as a Replacement Fluid for Therapeutic Plasma Exchange in Thrombotic Thrombocytopenic Purpura: A Single Center Retrospective Evaluation
Bianca Stefanello et al.
JOURNAL OF CLINICAL APHERESIS (2014)
Plasma exchange in the intensive care unit: A 10 year retrospective audit
Emily Paton et al.
AUSTRALIAN CRITICAL CARE (2014)
The Use of 50% Albumin/Plasma Replacement Fluid in Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura
Kerry L. O'Brien et al.
JOURNAL OF CLINICAL APHERESIS (2013)
ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatment
Yuji Hori et al.
TRANSFUSION (2013)
Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: A retrospective multicenter study
Serdal Korkmaz et al.
TRANSFUSION AND APHERESIS SCIENCE (2013)
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center
Antoine Froissart et al.
CRITICAL CARE MEDICINE (2012)
Plasma components: properties, differences, and uses
Richard John Benjamin et al.
TRANSFUSION (2012)
Theoretical Efficacy of Using Albumin/Plasma Versus Full Plasma Replacement in TTP
Mark E. Brecher et al.
JOURNAL OF CLINICAL APHERESIS (2011)
Survival and relapse in patients with thrombotic thrombocytopenic purpura
Johanna A. Kremer Hovinga et al.
BLOOD (2010)
Thrombotic thrombocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008: clinical outcomes and risk factors for relapse
Huichun Zhan et al.
TRANSFUSION (2010)
Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Comparison and stability of ADAMTS13 activity in therapeutic plasma products
Erik A. Scott et al.
TRANSFUSION (2007)
Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light
H Yarranton et al.
TRANSFUSION (2005)
The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome:: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency
DR Terrell et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet
G Rock et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura
H Yarranton et al.
TRANSFUSION MEDICINE (2004)
Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura
XL Zheng et al.
BLOOD (2004)
Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP)
ZR Zeigler et al.
JOURNAL OF CLINICAL APHERESIS (2001)
分享论文
